252 related articles for article (PubMed ID: 21450975)
1. Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice.
Wozniak KL; Young ML; Wormley FL
Clin Vaccine Immunol; 2011 May; 18(5):717-23. PubMed ID: 21450975
[TBL] [Abstract][Full Text] [Related]
2. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.
Wozniak KL; Ravi S; Macias S; Young ML; Olszewski MA; Steele C; Wormley FL
PLoS One; 2009 Sep; 4(9):e6854. PubMed ID: 19727388
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation.
Hardison SE; Herrera G; Young ML; Hole CR; Wozniak KL; Wormley FL
J Immunol; 2012 Oct; 189(8):4060-8. PubMed ID: 22984078
[TBL] [Abstract][Full Text] [Related]
4. Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection.
Wozniak KL; Hole CR; Yano J; Fidel PL; Wormley FL
Microbiology (Reading); 2014 Jul; 160(Pt 7):1440-1452. PubMed ID: 24760968
[TBL] [Abstract][Full Text] [Related]
5. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.
Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Wormley FL
J Immunol; 2014 Oct; 193(8):4060-71. PubMed ID: 25200956
[TBL] [Abstract][Full Text] [Related]
6. Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by γδ T cells.
Wozniak KL; Kolls JK; Wormley FL
BMC Immunol; 2012 Dec; 13():65. PubMed ID: 23216912
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.
Hardison SE; Wozniak KL; Kolls JK; Wormley FL
Infect Immun; 2010 Dec; 78(12):5341-51. PubMed ID: 20921149
[TBL] [Abstract][Full Text] [Related]
8. Role of IL-17A on resolution of pulmonary C. neoformans infection.
Wozniak KL; Hardison SE; Kolls JK; Wormley FL
PLoS One; 2011 Feb; 6(2):e17204. PubMed ID: 21359196
[TBL] [Abstract][Full Text] [Related]
9. CARD9 Is Required for Classical Macrophage Activation and the Induction of Protective Immunity against Pulmonary Cryptococcosis.
Campuzano A; Castro-Lopez N; Martinez AJ; Olszewski MA; Ganguly A; Leopold Wager C; Hung CY; Wormley FL
mBio; 2020 Jan; 11(1):. PubMed ID: 31911495
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain.
Wormley FL; Cox GM; Perfect JR
Microb Pathog; 2005; 38(2-3):113-23. PubMed ID: 15748813
[TBL] [Abstract][Full Text] [Related]
11. Diversity of the T-cell response to pulmonary Cryptococcus neoformans infection.
Lindell DM; Ballinger MN; McDonald RA; Toews GB; Huffnagle GB
Infect Immun; 2006 Aug; 74(8):4538-48. PubMed ID: 16861640
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection.
Hardison SE; Ravi S; Wozniak KL; Young ML; Olszewski MA; Wormley FL
Am J Pathol; 2010 Feb; 176(2):774-85. PubMed ID: 20056835
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with Recombinant
Specht CA; Lee CK; Huang H; Hester MM; Liu J; Luckie BA; Torres Santana MA; Mirza Z; Khoshkenar P; Abraham A; Shen ZT; Lodge JK; Akalin A; Homan J; Ostroff GR; Levitz SM
mBio; 2017 Nov; 8(6):. PubMed ID: 29184017
[TBL] [Abstract][Full Text] [Related]
14. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans.
Huffnagle GB; Toews GB; Burdick MD; Boyd MB; McAllister KS; McDonald RA; Kunkel SL; Strieter RM
J Immunol; 1996 Nov; 157(10):4529-36. PubMed ID: 8906831
[TBL] [Abstract][Full Text] [Related]
15. Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection.
Lindell DM; Moore TA; McDonald RA; Toews GB; Huffnagle GB
J Immunol; 2005 Jun; 174(12):7920-8. PubMed ID: 15944298
[TBL] [Abstract][Full Text] [Related]
16. Depletion of murine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans.
Mody CH; Chen GH; Jackson C; Curtis JL; Toews GB
J Lab Clin Med; 1993 Jun; 121(6):765-73. PubMed ID: 7685044
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses.
Chaturvedi AK; Weintraub ST; Lopez-Ribot JL; Wormley FL
Proteomics; 2013 Dec; 13(23-24):3429-41. PubMed ID: 24170628
[TBL] [Abstract][Full Text] [Related]
18. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells.
Huffnagle GB; Yates JL; Lipscomb MF
J Exp Med; 1991 Apr; 173(4):793-800. PubMed ID: 1672543
[TBL] [Abstract][Full Text] [Related]
19. Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain.
Wormley FL; Perfect JR; Steele C; Cox GM
Infect Immun; 2007 Mar; 75(3):1453-62. PubMed ID: 17210668
[TBL] [Abstract][Full Text] [Related]
20. CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans.
Mody CH; Paine R; Jackson C; Chen GH; Toews GB
J Immunol; 1994 Apr; 152(8):3970-9. PubMed ID: 8144964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
